LIVN
LivaNova PLC Ordinary Shares
Reaalajas hind
Hinnagraafik
Põhinäitajad
Turunäitajad
Avatud
$46.630
Kõrge
$46.630
Madal
$46.630
Maht
0.67M
Ettevõtte fundamentaalnäitajad
Kauplemisstatistika
Seotud uudised
CORE-VNS Study Further Validates Effectiveness of LivaNova's VNS Therapy on Severe Focal Seizures in Both Children and Adults with Drug-Resistant Epilepsy
Long-term, real-world evidence demonstrates early and lasting outcomes of adjunctive VNS Therapy on severe focal seizures LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology company, today announced
LivaNova Initiates Process with U.S. Centers for Medicare and Medicaid Services for Reconsideration of National Coverage for VNS Therapy for Treatment-Resistant Depression
Final critical papers on RECOVER clinical study data accepted, supporting the Company's submission for coverage reconsideration Strong 24-month top-line data for RECOVER clinical study demonstrates durability of VNS
Wolfe Research Upgrades LivaNova to Outperform, Announces $60 Price Target
Wolfe Research analyst Mike Polark upgrades LivaNova from Peer Perform to Outperform and announces $60 price target.
Seotud aktsiad
AKRO
Akero Therapeutics Inc.
RLMD
Relmada Therapeutics Inc.
INNV
InnovAge Holding Corp.
WVE
Wave Life Sciences Ltd. Ordinary Shares
KNSA
Kiniksa Pharmaceuticals International plc Ordinary Shares
Püsi kursis
Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.